RBCC Praises Partner TheraKine’s Fundraising Results in $60 Billion Drug Delivery Market

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp. (OTCBB: RBCC) today praised the fundraising results achieved by joint venture partner TheraKine, Ltd., as both companies work together to solve the problems posed by systemic drug delivery.

Help employers find you! Check out all the jobs and post your resume.